Perceptive Advisors LLC Aquestive Therapeutics, Inc. Transaction History

Perceptive Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$4.17 - $6.73 $5.78 Million - $9.33 Million	-1,385,720 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$4.65 - $7.79 $1.69 Million - $2.84 Million	-364,280 Reduced 20.82%	1,385,720 $7.41 Million
Q2 2020 Aug 14, 2020	BUY	$1.84 - $6.44 $3.22 Million - $11.3 Million	1,750,000 New	1,750,000 $8.51 Million
Q4 2018 Feb 14, 2019	SELL	$6.09 - $18.0 $7 Million - $20.7 Million	-1,150,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$15.0 - $18.96 $17.3 Million - $21.8 Million	1,150,000 New	1,150,000 $20.1 Million

121

43.3M

504K

148K

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $161M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.